From The Tribune
Center Owned by The Tribune TrustApproval of India-made version of HIV-prevention shot raises hopes in low-income countries
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
center · 1 outlet
The US Food and Drug Administration has approved an India-made generic version of the world’s only twice-a-year shot to prevent HIV — a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries. The announcement was made on Monday morning by the…
-
right · 1 outlet
The first supplies are expected to reach people by the end of 2026, with broader rollout across eligible countries expected in 2027
RSS excerpt
The US Food and Drug Administration has approved an India-made generic version of the world’s only twice-a-year shot to prevent HIV — a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries. The announcement was made on Monday morning by the…
